- Record: found
- Abstract: found
- Article: not found
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The REACH study evaluated the safety and efficacy of infliximab in children with moderately to severely active Crohn's disease.